Evidence map›Paper›PMID 42253990›Full record

ArticleFrontiers in immunology2026

Case Report: Presenting as optic neuritis-a biopsy-proven IgG4 anti-NF155-positive combined central and peripheral demyelination syndrome.

Yujing Peng, Xiaonan Wang, Weijiao Zhang, Ran Li, Jingting Peng, Jiawei Wang, Hanqiu Jiang

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yujing PengDepartment of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Xiaonan WangDepartment of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Weijiao ZhangDepartment of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Ran LiDepartment of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Jingting PengDepartment of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Jiawei WangDepartment of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Hanqiu JiangDepartment of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combined central and peripheral demyelination (CCPD) is a condition characterized by concurrent demyelination in both the central and peripheral nervous systems. To date, cases of CCPD presenting with isolated optic neuritis as the initial manifestation and positive for anti-neurofascin 155 (anti-NF155) antibodies are exceedingly rare. We herein report a case of a young male positive for anti-NF155 antibodies who developed severe optic neuritis and was subsequently diagnosed with CCPD via histopathological examination. This case highlights that CCPD may develop in patients presenting with optic neuritis as the initial manifestation, and underscores the critical importance of anti-NF155 antibody testing when concomitant peripheral neuropathy is identified.

Indexed as

AutoantibodiesCell Adhesion MoleculesDemyelinating DiseasesImmunoglobulin GNerve Growth FactorsOptic NeuritisAdultBiopsyHumansMagnetic Resonance ImagingMaleAutoantibodiesCell Adhesion MoleculesImmunoglobulin GNerve Growth FactorsNFASC protein, humananti-neurofascin 155case reportcombined central and peripheral demyelinationhistopathological examinationoptic neuritis

Identifiers

PMID42253990
PMCPMC13236885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.